MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Confronting loneliness and isolation in life after diagnosisby Nella George on October 23, 2026 at 2:00 pm
When my husband, Ty, received his myasthenia gravis (MG) diagnosis over three years ago, I didn’t know what to expect at first. Initially, we were in fight-or-flight mode. Between trying to figure out how to manage his symptoms, going to specialist appointments, and creating a new routine, we didn’t have much time to focus on The post Confronting loneliness and isolation in life after diagnosis appeared first on Myasthenia Gravis News.
- 10 things I wish I knew after my diagnosis of myasthenia gravisby Shawna Barnes on October 22, 2026 at 2:00 pm
The first time I heard those dreaded words, “You have myasthenia gravis” (MG), I felt such relief after searching so long for a diagnosis. That was quickly followed by an intense desire to learn everything I could about the condition. One of my biggest motivating factors was a strong desire to prove wrong the doctors The post 10 things I wish I knew after my diagnosis of myasthenia gravis appeared first on Myasthenia Gravis News.
- My challenges in life due to MG are causing some pre-marriage jittersby Sarah Bendiff on October 22, 2026 at 2:00 pm
In less than 30 days, I’ll be getting married and moving in with my future husband, the love of my life, who has lived through every stage of myasthenia gravis (MG) with me, from my diagnosis in 2018 to the grieving journey I am still going through today. But since we’ve never lived under the The post My challenges in life due to MG are causing some pre-marriage jitters appeared first on Myasthenia Gravis News.
- Study comparing key gMG treatment options finds similar efficacyby Michela Luciano, PhD on October 22, 2026 at 12:00 pm
Six weeks of treatment with Rystiggo (rozanolixizumab-noli) appears as effective as Vyvgart (efgartigimod alfa-fcab) at easing symptoms of generalized myasthenia gravis (gMG), reducing its impact on daily life, and improving quality of life, according to an indirect comparison analysis of treatment options. The analysis, based on data from three clinical trials that evaluated the treatments The post Study comparing key gMG treatment options finds similar efficacy appeared first on Myasthenia Gravis News.
- What the ‘Curse of the Bambino’ can teach us about living with MGby Mark Harrington on October 21, 2026 at 2:00 pm
Every October, on the faces of many New Englanders, particularly Bostonians, you’ll see a look that cannot be seen anywhere else in the country. In my imagination, it’s the same look you would expect on the face of someone who has seen a religious or ghostly apparition, or the awe of a scientist who has The post What the ‘Curse of the Bambino’ can teach us about living with MG appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.






